Cargando…
Polycythaemia Vera among Sudanese Patients with Special Emphasis on JAK2 Mutations
BACKGROUND: In recent years, a somatic point mutation in the Janus Kinase 2 (JAK2) gene (1849 G→T, V617F) has been reported to occur in over 90% of patients with polycythemia vera (PV). Another JAK2 mutation in exon 12 had been described and shown capable of activating erythropoietin signaling pathw...
Autores principales: | Ibrahim, Ibrahim Khidir, Hassan, Rosline, Ali, Elshazli Widaa, Omer, Awad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485582/ https://www.ncbi.nlm.nih.gov/pubmed/30677867 http://dx.doi.org/10.31557/APJCP.2019.20.1.41 |
Ejemplares similares
-
Masked polycythaemia vera is genetically intermediate between JAK2V617F mutated essential thrombocythaemia and overt polycythaemia vera
por: Tiong, I S, et al.
Publicado: (2016) -
The treatment of polycythaemia vera: an update in the JAK2 era
por: Finazzi, G., et al.
Publicado: (2007) -
Koilonychia and Polycythæmia Vera
por: Glazebrook, A. J.
Publicado: (1944) -
Unusual Neurological Symptoms in Polycythæmia Rubra Vera
por: Grunberg, A., et al.
Publicado: (1950) -
Polycythaemia Vera JAK 2 Mutation in a Patient with Underlying Chronic Obstructive Pulmonary Disease at a Primary Care Setting
por: Mahmud, Rafidah, et al.
Publicado: (2020)